Abstract:Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases worldwide with an unclear mechanism. Long non-coding RNAs (lncRNAs) have recently emerged as important regulatory molecules. To better understand NAFLD pathogenesis, lncRNA and messenger RNA (mRNA) microarrays were conducted in an NAFLD rodent model. Potential target genes of significantly changed lncRNA were predicted using cis/trans-regulatory algorithms. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were then performed to explore their function. In the current analysis, 89 upregulated and 177 downregulated mRNAs were identified, together with 291 deregulated lncRNAs. Bioinformatic analysis of these RNAs has categorized these RNAs into pathways including arachidonic acid metabolism, circadian rhythm, linoleic acid metabolism, peroxisome proliferator-activated receptor (PPAR) signaling pathway, sphingolipid metabolism, steroid biosynthesis, tryptophan metabolism and tyrosine metabolism were compromised. Quantitative polymerase chain reaction (qPCR) of representative nine mRNAs and eight lncRNAs (named fatty liver-related lncRNA, FLRL) was conducted and this verified previous microarray results. Several lncRNAs, such as FLRL1, FLRL6 and FLRL2 demonstrated to be involved in circadian rhythm targeting period circadian clock 3 (Per3), Per2 and aryl hydrocarbon receptor nuclear translocator-like (Arntl), respectively. While FLRL8, FLRL3 and FLRL7 showed a potential role in PPAR signaling pathway through interaction with fatty acid binding protein 5 (Fabp5), lipoprotein lipase (Lpl) and fatty acid desaturase 2 (Fads2). Functional experiments showed that interfering of lncRNA FLRL2 expression affected the expression of predicted target, circadian rhythm gene Arntl. Moreover, both FLRL2 and Arntl were downregulated in the NAFLD cellular model. The current study identified lncRNA and corresponding mRNA in NAFLD, providing new insight into the pathogenesis of NAFLD. Moreover, we identified a new lncRNA FLRL2, that might participate NAFLD pathogenesis mediated by Arntl.

The Roles and Mechanisms of Lncrnas in Liver Fibrosis

Regulatory Long Non-Coding RNAs of Hepatic Stellate Cells in Liver Fibrosis (Review)

Retard or Exacerbate: Role of Long Non-Coding RNA Growth Arrest-Specific 5 in the Fibrosis

Emerging Roles Of Long Non-Coding Rnas In Renal Fibrosis

Integrated Profiling of Long Non-Coding RNAs and Mrnas Identifies Novel Regulators Associated with Liver Fibrosis.

Role of noncoding RNAs in liver fibrosis

The role of lncRNA-mediated ceRNA regulatory networks in liver fibrosis

Long Noncoding RNA: a New Contributor and Potential Therapeutic Target in Fibrosis

The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)

The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways

LncRNA: Shedding Light on Mechanisms and Opportunities in Fibrosis and Aging

Critical Effects of Long Non-Coding RNA on Fibrosis Diseases.

LncRNA Airn Maintains LSEC Differentiation to Alleviate Liver Fibrosis Via the KLF2-eNOS-sGC Pathway

The mechanism of lncRNA H19 in fibrosis and its potential as novel therapeutic target

Genome‑wide identification of long noncoding RNAs in CCl4‑induced liver fibrosis via RNA sequencing.

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

The role of ferroptosis-related non-coding RNA in liver fibrosis

LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles

LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review

Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis.

Long Noncoding RNAs Expressed in Human Hepatic Stellate Cells Form Networks with Extracellular Matrix Proteins